Cargando…

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative

We explored the association between CYP2C19/3A4 mediated drug-gene-interaction (DGI), drug-drug-interaction (DDI) and drug-drug-gene-interaction (DDGI) and (es)citalopram dispensing course. A cohort study was conducted among adult Caucasians from the Lifelines cohort (167,729 participants) and linke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahar, Muh. Akbar, Lanting, Pauline, Bos, Jens H. J., Sijmons, Rolf H., Hak, Eelko, Wilffert, Bob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720126/ https://www.ncbi.nlm.nih.gov/pubmed/33260705 http://dx.doi.org/10.3390/jpm10040256

Ejemplares similares

Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
por: Hunt, Nicholas B., et al.
Publicado: (2022)

The impact of CYP2D6 mediated drug–drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine
por: Bahar, Muh. Akbar, et al.
Publicado: (2018)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

The effect of feedback on cardiovascular risk factors on optimization of primary prevention: The PharmLines initiative
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative
por: Sediq, Rahmat, et al.
Publicado: (2018)

Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies
por: Daud, Aizati N. A., et al.
Publicado: (2017)

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
por: Steenhuis, Dennis, et al.
Publicado: (2022)

Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients
por: Wang, Yuanyuan, et al.
Publicado: (2019)

Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
por: HAISMA, Marjolijn S., et al.
Publicado: (2023)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
por: Bahar, Muh. Akbar, et al.
Publicado: (2018)

P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
por: Daud, Aizati N. A., et al.
Publicado: (2015)

Understanding and preventing drug–drug and drug–gene interactions
por: Tannenbaum, Cara, et al.
Publicado: (2014)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
por: Spanakis, Marios, et al.
Publicado: (2019)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
por: Asiimwe, Innocent G, et al.
Publicado: (2022)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Predicting Drug-Target Interactions Using Drug-Drug Interactions
por: Kim, Shinhyuk, et al.
Publicado: (2013)

Gene-Drug Interaction in Stroke
por: Amici, Serena, et al.
Publicado: (2011)

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population
por: Ashcraft, Kristine, et al.
Publicado: (2022)

Drug-drug interactions in the ICU
por: Ray, S, et al.
Publicado: (2009)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions
por: Groza, Vlad, et al.
Publicado: (2021)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

Drug–drug Interactions in Hospitalized Cardiac Patients
por: Mateti, UV, et al.
Publicado: (2011)

Renal drug transporters and their significance in drug–drug interactions
por: Yin, Jia, et al.
Publicado: (2016)

Drug Interactions
por: Dollery, C.T., et al.
Publicado: (1980)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019)

Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction
por: Gomez Lumbreras, Ainhoa, et al.
Publicado: (2022)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019)

Drug-Drug Interaction Pattern Recognition
por: Duan, John Z.
Publicado: (2012)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
por: Vilar, Santiago, et al.
Publicado: (2013)

Leveraging genetic interactions for adverse drug-drug interaction prediction
por: Qian, Sheng, et al.
Publicado: (2019)

PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool
por: Chen, Yen-Wei, et al.
Publicado: (2022)

Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients
por: Wasylewicz, Arthur T.M., et al.
Publicado: (2022)

Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge
por: Takeda, Takako, et al.
Publicado: (2017)

PharmGKB Drug Data Normalization with NDF-RT
por: Zhu, Qian, et al.
Publicado: (2013)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions
por: Kim, Eunyoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mrhfait3gtpuljsk7eco84rtvd